Can we conclude a potential therapeutic action for Parkinson's disease by using postmortem tissue and a preclinical model based on an exogenous neurotoxin?
| Author | dc.contributor.author | Segura Aguilar, Juan | |
| Admission date | dc.date.accessioned | 2018-11-08T19:30:31Z | |
| Available date | dc.date.available | 2018-11-08T19:30:31Z | |
| Publication date | dc.date.issued | 2018 | |
| Cita de ítem | dc.identifier.citation | Cell Death and Disease (2018) 9:748 | es_ES |
| Identifier | dc.identifier.other | 10.1038/s41419-018-0798-0 | |
| Identifier | dc.identifier.uri | https://repositorio.uchile.cl/handle/2250/152499 | |
| Patrocinador | dc.description.sponsorship | Supported by FONDECYT 1170033 | es_ES |
| Lenguage | dc.language.iso | en | es_ES |
| Publisher | dc.publisher | SpringerNature | es_ES |
| Type of license | dc.rights | Attribution-NonCommercial-NoDerivs 3.0 Chile | * |
| Link to License | dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/cl/ | * |
| Source | dc.source | Cell Death & Disease | es_ES |
| Keywords | dc.subject | Alpha-Synuclein | es_ES |
| Keywords | dc.subject | Pathology | es_ES |
| Keywords | dc.subject | Dopamine | es_ES |
| Título | dc.title | Can we conclude a potential therapeutic action for Parkinson's disease by using postmortem tissue and a preclinical model based on an exogenous neurotoxin? | es_ES |
| Document type | dc.type | Artículo de revista | |
| Cataloguer | uchile.catalogador | rvh | es_ES |
| Indexation | uchile.index | Artículo de publicación ISI | es_ES |
| Indexation | uchile.index | Artículo de publicación SCOPUS |
Files in this item
This item appears in the following Collection(s)
-
Artículos de revistas
Artículos de revistas
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 Chile